Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
1,202
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection

Lunzhi YuanState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Xuan LiuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Liang ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Yali ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Yao ChenState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Xiaoling LiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Kun WuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Jiali CaoState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Wangheng HouState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Yuqiong QueState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Jun ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Hua ZhuDepartment of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical SchoolRutgers University 225 Warren Street 070101NewarkNJUSA
,
Quan YuanState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. ChinaCorrespondence[email protected]
,
Qiyi TangDepartment of MicrobiologyHoward University College of Medicine20059WashingtonDCUSACorrespondence[email protected]
,
Tong ChengState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. ChinaCorrespondence[email protected]
&
Ningshao XiaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. ChinaORCID Iconhttp://orcid.org/0000-0003-0179-5266
ORCID Icon show all
Pages 1-17 | Received 01 May 2018, Accepted 06 Jul 2018, Published online: 10 Aug 2018

References

  • DienstagJLHepatitis B virus infectionN. Engl. J. Med.2008359 1486 150010.1056/NEJMra0801644
  • TrepoCChanHLLokAHepatitis B virus infectionLancet20143842053206310.1016/S0140-6736(14)60220-8
  • LiangTJPresent and future therapies of hepatitis B: from discovery to cureHepatology2015621893190810.1002/hep.280254681668
  • KockJEfficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virusJ. Virol.2001755084508910.1128/JVI.75.11.5084-5089.2001114913
  • GriponPHepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxideJ. Virol.19886241364143253845
  • GallePRIn vitro experimental infection of primary human hepatocytes with hepatitis B virusGastroenterology199410666467310.1016/0016-5085(94)90700-5
  • WashburnMLA humanized mouse model to study hepatitis C virus infection, immune response, and liver diseaseGastroenterology20111401334134410.1053/j.gastro.2011.01.0013066273
  • BissigKDHuman liver chimeric mice provide a model for hepatitis B and C virus infection and treatmentJ. Clin. Invest.201012092493010.1172/JCI400942827952
  • DandriMRepopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virusHepatology20013398198810.1053/jhep.2001.23314
  • KosakaKA novel TK-NOG based humanized mouse model for the study of HBV and HCV infectionsBiochem. Biophys. Res. Commun.201344123023510.1016/j.bbrc.2013.10.040
  • TsugeMInfection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virusHepatology2005421046105410.1002/hep.20892
  • CarpentierAEngrafted human stem cell-derived hepatocytes establish an infectious HCV murine modelJ. Clin. Invest.20141244953496410.1172/JCI754564347235
  • BilityMTHepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophagesPLoS. Pathog.201410e100403210.1371/journal.ppat.10040323961374
  • SugiyamaMDirect cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytesGastroenterology200913665262 e310.1053/j.gastro.2008.10.048
  • Mason, W. S. Animal models and the molecular biology of hepadnavirus infection. Cold Spring Harb. Perspect. Med. 5, a021352 (2015).
  • de JongYPRiceCMPlossANew horizons for studying human hepatotropic infectionsJ. Clin. Invest.201012065065310.1172/JCI423382827969
  • AllweissLDandriMExperimental in vitro and in vivo models for the study of human hepatitis B virus infectionJ. Hepatol.201664S17S3110.1016/j.jhep.2016.02.012
  • ThomasELiangTJExperimental models of hepatitis B and C - new insights and progressNat. Rev. Gastroenterol. Hepatol.20161336237410.1038/nrgastro.2016.375578419
  • DandriMPetersenJChimeric mouse model of hepatitis B virus infectionJ. Hepatol.20125649349510.1016/j.jhep.2011.05.037
  • GriponPInfection of a human hepatoma cell line by hepatitis B virusProc. Natl. Acad. Sci. USA200299156551566010.1073/pnas.232137699
  • CerecVTransdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitorHepatology20074595796710.1002/hep.21536
  • HantzOPersistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cellsJ. Gen. Virol.20099012713510.1099/vir.0.004861-0
  • PhillipsSAlisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen productionGastroenterology201514840314 e710.1053/j.gastro.2014.10.004
  • GriponPCannieIUrbanSEfficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface proteinJ. Virol.2005791613162210.1128/JVI.79.3.1613-1622.2005544121
  • NunnADThe histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cellsSci. Rep.2016610.1038/srep280254913258
  • HiguchiYThe human hepatic cell line HepaRG as a possible cell source for the generation of humanized liver TK-NOG miceXenobiotica20144414615310.3109/00498254.2013.836257
  • XiaYHuman stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactionsJ. Hepatol.20176649450310.1016/j.jhep.2016.10.009
  • ShanJIdentification of small molecules for human hepatocyte expansion and iPS differentiationNat. Chem. Biol.2013951452010.1038/nchembio.12703720805
  • FanFPharmacological targeting of kinases MST1 and MST2 augments tissue repair and regenerationSci. Transl. Med20168352ra10810.1126/scitranslmed.aaf2304
  • ShiXLImproved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytesCell Res.20162620621610.1038/cr.2016.64746613
  • YuanLA chimeric humanized mouse model by engrafting the human induced pluripotent stem cell-derived hepatocyte-like cell for the chronic hepatitis B virus infectionFront. Microbiol.2018990810.3389/fmicb.2018.009085952038
  • DurantelDZoulimFNew antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virusJ. Hepatol.201664S117S13110.1016/j.jhep.2016.02.016
  • BlankAFirst-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex BJ. Hepatol.20166548348910.1016/j.jhep.2016.04.013
  • WatashiKCyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)Hepatology2014591726173710.1002/hep.269824265264
  • VolzTThe entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virusJ. Hepatol.20135886186710.1016/j.jhep.2012.12.008
  • KanekoMA novel tricyclic polyketide, vanitaracin A, specifically inhibits the entry of hepatitis B and D viruses by targeting sodium taurocholate cotransporting polypeptideJ. Virol.201589119451195310.1128/JVI.01855-154645323
  • KoCThe FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptideAntivir. Ther.20152083584210.3851/IMP2965
  • NiYUrbanSStem cell-derived hepatocytes: a promising novel tool to study hepatitis B virus infectionJ. Hepatol.20176647347510.1016/j.jhep.2016.11.027
  • SellsMAZelentAZShvartsmanMAcsGReplicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virionsJ. Virol.19886228362844253719
  • PaganelliMDifferentiated umbilical cord matrix stem cells as a new in vitro model to study early events during hepatitis B virus infectionHepatology201357596910.1002/hep.26006
  • LuciforaJControl of hepatitis B virus replication by innate response of HepaRG cellsHepatology201051637210.1002/hep.23230
  • SchulzeAGriponPUrbanSHepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycansHepatology2007461759176810.1002/hep.21896
  • LuangsaySExpression and functionality of Toll- and RIG-like receptors in HepaRG cellsJ. Hepatol.2015631077108510.1016/j.jhep.2015.06.022
  • LuangsaySEarly inhibition of hepatocyte innate responses by hepatitis B virusJ. Hepatol.2015631314132210.1016/j.jhep.2015.07.014
  • KudoTEndoYTaguchiRYatsuMItoKMetronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytesXenobiotica20154541341910.3109/00498254.2014.990948
  • KanekoAIn vitro model for the prediction of clinical CYP3A4 induction using HepaRG cellsXenobiotica20093980381010.3109/00498250903184018
  • ZhangTYProlonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigenGut20166565867110.1136/gutjnl-2014-308964
  • AzumaHRobust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- miceNat. Biotechnol.20072590391010.1038/nbt13263404624
  • WuYSleeping Beauty transposon-based system for rapid generation of HBV-replicating stable cell linesJ. Virol. Methods20162349610010.1016/j.jviromet.2016.04.010
  • HuangCHInfluence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donorsJ. Hepatol.20125772072910.1016/j.jhep.2012.05.009
  • WuHLRNA interference-mediated control of hepatitis B virus and emergence of resistant mutantGastroenterology200512870871610.1053/j.gastro.2004.12.007
  • HirtBSelective extraction of polyoma DNA from infected mouse cell culturesJ. Mol. Biol.19672636536910.1016/0022-2836(67)90307-5
  • GuoHCharacterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formationJ. Virol.200781124721248410.1128/JVI.01123-072169032

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.